Mehmet Murat Zerey: Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Mehmet Murat Zerey, Medical Oncologist and Research Associate at Miami Cancer Institute, shared a post on LinkedIn:
“Thrilled to share that our review, “Hypofractionated Radiotherapy for Soft Tissue Sarcomas” has been published in Cancers! This work explores the emerging role of hypofractionated radiation in soft tissue sarcomas, highlighting its potential benefits in efficacy, toxicity reduction, and treatment convenience.
A huge thank you to my co-authors, Dr. Amna Gul, Dr. Noah S. Kalman and Dr. Matthew D. Hall, for their invaluable contributions and support. Grateful for the opportunity to contribute to the evolving discussion on optimizing radiotherapy strategies for sarcoma patients.
Check out the full article here.”
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Authors: Mehmet Murat Zerey et al.
Further Reading:
Radiotherapy for Cervical Cancer: Types, Success Rate, Side Effects And More
What Is Adaptive Radiotherapy and How Does It Work? Pros and Cons
What Is Stereotactic Ablative Radiotherapy (SABR) and How It Works? Pros and Cons
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023